Driehaus Capital Management’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-185,140
Closed -$4.91M 382
2023
Q4
$4.91M Sell
185,140
-1,266,206
-87% -$36.9M 0.06% 268
2023
Q3
$66.3M Buy
1,451,346
+102,524
+8% +$4.75M 0.86% 23
2023
Q2
$55.6M Buy
1,348,822
+314,973
+30% +$10.3M 0.7% 30
2023
Q1
$32.1M Buy
1,033,849
+142,233
+16% +$4.58M 0.45% 57
2022
Q4
$17.9M Buy
891,616
+610,425
+217% +$13.1M 0.27% 130
2022
Q3
$3.96M Buy
+281,191
New +$3.78M 0.06% 286

Other funds holding AEHR

Driehaus Capital Management's AEHR Position: Q1 2024 in Review

Driehaus Capital Management sold out of Aehr Test Systems (AEHR) in Q1 2024, closing a stake of 185,140 shares — an estimated $4.91M sold.

Driehaus Capital Management first reported a position in AEHR in Q3 2022 and held it in 6 quarters. The position peaked at $66.3M in Q3 2023. 132 funds tracked by Wall St. Rank hold AEHR as of Q1 2024.

  • Driehaus Capital Management reported no remaining Aehr Test Systems position as of Q1 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 185,140 Aehr Test Systems shares in Q1 2024, an estimated $4.91M.
  • Driehaus Capital Management first reported a position in Aehr Test Systems in Q3 2022 and held it in 6 quarters.
  • Driehaus Capital Management's Aehr Test Systems position peaked at $66.3M in Q3 2023.
  • 132 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.